This article features deals sourced directly by Gizmodo and produced independently of the editorial team. We may earn a commission when you buy through links on the site. Reading time 2 minutes ...
South Korean crypto entrepreneur and prosecuted fraudster Do Kwon was sentenced to 15 years in prison by a US federal judge in the Southern District of New York on Thursday. Kwon cut a solemn figure ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
Three Republican-led states have challenged the Food and Drug Administration’s (FDA) approval of a generic form of the abortion pill mifepristone earlier this year, arguing the agency’s decision had ...
The FDA approved a new generic form of mifepristone in September, expanding the accessibility of a common abortion medication. Missouri Attorney General Catherine Hanaway is taking over a lawsuit ...
MISSOURI, USA — Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration’s recent decision to approve a new generic brand of ...
This article is part of Gizmodo Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Reading time 2 minutes Gaming on a cramped 7.9-inch ...
A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...
Q. I am dealing with a horrible decline from generic Wellbutrin XL. I’ve been on samples of the name brand and my symptoms slowly improved. The generic is definitely a problem. My insurance won’t ...
More than 140,000 bottles of a commonly prescribed statin have been recalled due to “failed dissolution specifications,” according to the U.S. Food and Drug Administration. The New Jersey-based Ascend ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...